To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

US tests Minuteman III as Sentinel successor ICBM programme struggles

7th June 2024 - 11:00 GMT | by Flavia Camargos Pereira in Kansas City

RSS

An unarmed MMIII ICBM was launched from Vandenberg Space Force Base, California on 4 June. (Photo: US Space Force)

In service for nearly 60 years, the Minuteman intercontinental ballistic missile is due to be replaced by the Sentinel, but cost overruns and delays continue to plague this successor programme.

Earlier this week the USAF and US Space Force launched an unarmed Minuteman III intercontinental ballistic missile (MMIII ICBM) equipped with one re-entry vehicle. The test comes at a time when the Pentagon is evaluating how to progress with the Sentinel programme which has been experiencing cost overruns and delays.

The MMIII was first deployed in the 1960s. Over the last five decades, the USAF has conducted various life extension efforts to update its component systems.

The ICBM is expected to be replaced by the Sentinel, which should be delivered from 2029 to 2036. This effort comprises production of the missile

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 2 free stories per week
  • Daily news round-up email service
  • Access to all Decisive Edge email newsletters
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
Start your free trial
Flavia Camargos Pereira

Author

Flavia Camargos Pereira


Flavia Camargos Pereira is a North America editor at Shephard Media. She joined the company …

Read full bio

Share to

Linkedin